冠状动脉粥样硬化性心脏病高危患者的强化降脂与瑞舒伐他汀

Rosuvastatin and Intensive Lipid Lowering in High Risk Patients with Coronary Heart Disease

瑞舒伐他汀具有独特的临床药理特点,其降脂疗效、安全性、成本-效益比均优于其他他汀类药物,具有降脂疗效以外的"多效性",是冠状动脉粥样硬化性心脏病高危患者强化降脂、减少心血管事件的最佳选择,呼吁瑞舒伐他汀能早日在基层医疗单位普及。

Rosuvastatin has unique clinical pharmacology characteristics including： lipid-lowering effects,and a safety and cost-benefit ratio that is superior to other statins.It also has many curative effects aside from lipid-lowering,called ＂pleiotropy＂ effects.This makes it the best choice for high risk coronary heart disease patients to intensively lower their lipids,and reduce cardiovascular events.This article reviews the benefits of using rosuvastatin for patients in a basic-level medical unit as early as possible.